The Rare Genetic Steroid Disorders Consortium
Participating Clinical Centers
Columbia University Logo

New York State Psychiatric Institute Columbia College of Physicians & Surgeons

Contact Information:

Heino F. L. Meyer-Bahlburg, Dr. rer. nat.
Professor of Clinical Psychology (in Psychiatry)

Phone: 212-543-5299
Fax: 212-543-5966
E-mail: meyerb@childpsych.columbia.edu

About Us:

The Program of Developmental Psychoendocrinology comprises a research program and a small Psychoendocrine Clinic. The research focuses on the development of gender, sexuality, cognitive abilities, psychiatric outcome, and quality of life as a function of biological and psychosocial factors. Psychoendocrine research projects involve children, adolescents, and adults with endocrine disorders of prenatal onset (intersexuality) or with a history of prenatal exposure to exogenous hormones, and hormonally presumably normal individuals with gender variants, using both patient and community samples.

The Psychoendocrine Clinic serves children, adolescents, and adults with intersexuality, and (non-intersex) children and adolescents with gender identity disorder.

Our specific role in the Rare Genetic Steroids Disorders Consortium is the development of psychological protocols for the assessment of gender outcome and related psychological features of children, adolescents, and adults with various categories of intersexuality and the analysis and evaluation of such outcomes.

Useful Links

http://childpsych.columbia.edu/s_faculty_01.html

Current Clinical Trials:

Trial information is under development - please check back for updates!

Publications:

  1. Meyer-Bahlburg, H.F.L.: Gender and sexuality in classic congenital adrenal hyperplasia. Endocrinology and Metabolism Clinics of North America, 30 (1), 155-171, 2001.
  2. Meyer-Bahlburg, H.F.L.: Gender assignment and reassignment in intersexuality: Controversies, data, and guidelines for research. In: S.A. Zderic, D.A. Canning, M.C. Carr, & H. McC. Snyder (eds.), Pediatric gender assignment: A critical reappraisal . Advances in Experimental Medicine and Biology, Vol. 511. New York: Kluwer Academic/Plenum, pp. 199-223, 2002.
  3. Meyer-Bahlburg, H.F.L.: Rationale for gender assignment. The Endocrinologist 13 , 224-226, 2003.
  4. Meyer-Bahlburg, H.F.L.: Gender assignment and psychosocial management. In L. Martini (ed.), Encyclopedia of Endocrine Diseases, Vol. 2 . San Diego, CA: Academic Press (Elsevier), pp. 125-134, 2004.
  5. Meyer-Bahlburg, H.F.L., & Blizzard, R.M.: Research on intersex - summary of a planning workshop.The Endocrinologist 14 , 59-69, 2004.
  6. Meyer-Bahlburg, H.F.L., Dolezal, C., Baker, S.W., Carlson, A.D., Obeid, J.S., & New, M.I.: Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. Journal of Clinical Endocrinology and Metabolism 89 , 610-614, 2004.
  7. Meyer-Bahlburg, H.F.L., Dolezal, C., Baker, S.W., Carlson, A.D., Obeid, J.S., & New, M.I.: Prenatal androgenization affects gender-related behavior but not gender identity in 5-12 year old girls with congenital adrenal hyperplasia. Archives of Sexual Behavior 33 , 97-104, 2004.
  8. Meyer-Bahlburg, H.F.L., Migeon, C.J., Berkovitz, G.D., Gearhart, J.P., Dolezal, C., & Wisniewski, A.B.: Attitudes of adult 46,XY intersex persons to clinical management policies. Journal of Urology, 171 , 1615-1619, 2004.